Company performance
Add to research
Current Price
as of Feb 11, 2025$1.88
P/E Ratio
N/A
Market Cap
$283.25M
Description
Add to research
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Metrics
Add to research
Overview
- HQBoston, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerIRWD
- Price$1.88+6.21%
Trading Information
- Market cap$283.25M
- Float96.98%
- Average Daily Volume (1m)4,353,596
- Average Daily Volume (3m)2,957,767
- EPS-$0.02
Company
- Revenue$378.42M
- Rev growth (1yr)-19.47%
- Net income$3.65M
- Gross margin99.45%
- EBITDA margin37.84%
- EBITDA$34.66M
- EV$1.19B
- EV/Revenue3.14
- P/EN/A
- P/S0.75
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account